BACKGROUND Femoral access is the gold standard for transcatheter aortic valve replacement (TAVR). Guidelines recommend reconsidering surgery when this access is not feasible. However, alternative peripheral accesses exist, although they have not been accurately compared with femoral access.
S ince its introduction in 2002, transcatheter aortic valve replacement (TAVR) has expanded rapidly as an alternative to surgical aortic valve replacement in patients at high and intermediate procedural risk (1) (2) (3) (4) .
Femoral peripheral (FP) access is the most studied and widely used access for TAVR procedures; it allows exclusive percutaneous intervention (5) . However, despite the improvement in device profiles and procedural techniques, FP access cannot be performed in approximately 10% to 15% of patients due to iliofemoral arteriopathy, tortuosity, severe calcifications, aortic aneurysm, mural thrombus, or previous vascular surgery (6) . Current guidelines recommend that surgery be reconsidered in patients ineligible for FP access, mainly based on studies that assessed the safety of transapical access (1, 7) . However, alternative nonfemoral peripheral (n-FP) accesses were recently developed (8) (9) (10) (11) . No randomized trial has compared the outcome of TAVR according to the access site, and observational studyÀderived comparisons have been limited by the difference in patient characteristics between the groups, with patients with more severe disease undergoing n-FP TAVR. Although propensity-matched comparison of transthoracic and FP TAVR has shown higher rates of adverse periprocedural events and death with central or transthoracic access (e.g., transapical or transaortic) (12, 13) , no similar comparisons have been made between n-FP (transcarotid or trans-subclavian) and FP TAVR.
Using data from the national prospective Beurtheret et al. and December 31, 2017 were included in the study.
Patients with missing data on valve type, access site, or propensity score variables (Online Table 1 ) were excluded from the analysis. The study flowchart is presented in Figure 1 .
This was a multicentric observational study in which each center used its own technique. FP TAVR was percutaneous in most cases.
It was a surgical approach in all cases of n-FP TAVR.
The surgical cutdown of the trans-subclavian access (including transaxillary or distal subclavian) was performed through an infraclavicular incision respecting the brachial plexus. In case of a carotid approach, a 3-to 4-cm long, low cervical incision was performed to expose the sternocleidomastoid muscle.
The jugular vein, the Vagus nerve, and the respiratory tract were identified. Theoretically, the left access for n-FP TAVR was often preferred over the right access because it provided superior coaxial alignment with the ascending aorta and optimal positioning of the prosthesis.
Conscious sedation with local anesthesia or general anesthesia was possible with all pathways. Femoral or Nonfemoral Peripheral TAVR Beurtheret et al. IMPACT OF ACCESS SITE ON THE OUTCOME. Impact of access type on outcomes in the unmatched population is presented in Online Values are n (%) unless otherwise indicated. *Odds ratio (OR) expressing the excess of risk of complication for nonfemoral peripheral transcatheter aortic valve replacement after adjustment for prosthesis type and time period.
CI ¼ confidence interval; STEMI ¼ ST-segment elevation myocardial infarction. Femoral or Nonfemoral Peripheral TAVR complete per-period subanalysis is shown in Online recommend that a surgical option be reconsidered (1) . However, n-FP accesses have emerged as alternatives to FP, although no dedicated devices have been made for n-FP access (8, 9, 18) . Those n-FP accesses have not been accurately compared with surgery or FP TAVR.
From an organizational point of view, n-FP TAVR is more invasive and more demanding than FP TAVR, in which procedural duration has decreased with time and general anesthesia can now be avoided in experienced centers (19) . This led to the development of minimalistic TAVR with a shorter length of hospital stay and a simplification of procedure organization (20) . Regarding safety and outcome, comparison of access types in observational studies has been limited by the great variability among patients who undergo different accesses, with patients with more severe disease undergoing n-FP TAVR. In our study, we performed propensity-based matching to allow an Femoral or Nonfemoral Peripheral TAVR accurate comparison between groups. We did not observe any difference in procedural mortality or complication rates between FP and n-FP access, but n-FP access was associated with a lower rate of major vascular complications and unplanned vascular repairs compared with FP access. This confirmed the findings of previous studies (21, 22) .
The absence of increased risk of disabling stroke in n-FP TAVR was another major finding in our study.
Despite all the advances in TAVR techniques, stroke remained the most feared complication, with evidence of silent and apparent microembolism in 50%
to 94% of patients within the first month after TAVR (22, 23) . Cerebrovascular events were mainly attrib- Second, for the sake of matching, we excluded patients with incomplete data. However, unadjusted comparison between n-FP and FP approaches among excluded patients with incomplete data showed similar results, indicating that this did not introduce any bias. Third, only symptomatic strokes were reported, and there was no systematic cerebral imaging.
Therefore, the rate of silent cerebrovascular embolisms was not assessed. However, the impact of these silent microembolisms remains to be determined. Femoral or Nonfemoral Peripheral TAVR
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